Abbott Medical Optics

What Abbott Medical Optics does

Abbott Medical Optics is an operating division of Abbott Laboratories (NYSE: ABT) that develops and commercializes ophthalmic medical devices, with a core franchise centered on the Verisyse phakic intraocular lens used for minimally invasive vision correction in patients with refractive errors such as myopia, hyperopia, and astigmatism. The division's flagship product is positioned as a lens-based alternative to laser-based LASIK surgery, addressing a horizontal patient population that prefers or requires an implant-based correction approach. Verisyse holds an estimated 56% global share of its specific phakic IOL segment, with the only other meaningful competitor being Ophtec BV at 44%, establishing the unit as one of two principal vendors in a niche but defensible medical-device category.

The division generates revenue primarily through hardware sales of phakic intraocular lenses, distributed globally across North America (39% of served market), Europe (29%), Asia-Pacific (24%), and the Middle East & Africa (8%). Abbott Medical Optics also serves adjacent ophthalmic consumer needs including contact lens wearers and patients with dry or irritated eyes, as indicated by its product-line framing. The broader product portfolio historically extended into femtosecond laser technology following the 2007 acquisition of IntraLase, although current product depth beyond Verisyse is not detailed in the source data. The division is operated inside Abbott Laboratories, leveraging the parent's regulatory, manufacturing, and commercial infrastructure rather than functioning as an independent enterprise, and its corporate domain (abbottmedicaloptics.com) currently displays a non-functional default hosting page, suggesting limited direct-to-market digital presence.

Name

Abbott Medical Optics

Website

https://abbottmedicaloptics.com

Company type

Private

Founded year

1976

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

Abbott Medical Optics is a division of Abbott Laboratories that develops and sells the Verisyse phakic intraocular lens and adjacent ophthalmic products for patients with refractive errors, contact lens wearers, and dry-eye sufferers, holding roughly 56% global share in its core IOL segment.

Ownership category

akta.pro rank

Product category

Ophthalmic Medical Devices

NAICS

Ophthalmic Goods Manufacturing (339115), Surgical Appliance and Supplies Manufacturing (339113), Surgical and Medical Instrument Manufacturing (339112)

SIC

Ophthalmic Goods (3851), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Refractive Surgery Systems (Excimer/Femtosecond Lasers, Phakic IOL Systems, Wavefront/Guidance) (HLAHAJAG)

akta.pro secondary industries

Cataract Surgery Systems & IOLs (Phaco Systems, IOLs, Intraoperative Aberrometry, Viscoelastics) (HLAHAJAH), Cornea, External Disease & Refractive Surgery (LASIK/PRK) (HLAKAKAF), Contact Lenses & Care Systems (Soft/RGP/Scleral Lenses; Cleaning/Disinfection Solutions) (HLAHAJAE)

Keywords

• Ophthalmic medical devices
• Intraocular lenses
• Refractive surgery
• Vision correction implants
• Cataract surgery devices

Headquarters

HQ city

Lucerne Valley

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Supply Chain, Technology or R&D, Marketing or Sales

Revenue model

1. Phakic Intraocular Lens Sales: Abbott Medical Optics generates revenue through the sale of Verisyse phakic intraocular lenses for refractive vision correction, positioning within the broader ophthalmic devices market.

Core offering

Abbott Medical Optics designs, manufactures, and sells ophthalmic medical devices for vision correction procedures, with its flagship product being the Verisyse Lens — a phakic intraocular lens implanted in the eye to correct refractive errors (myopia, hyperopia, astigmatism) as an alternative to LASIK laser surgery. The division operates within the ophthalmic surgical devices market and also oversees femtosecond laser technology for refractive surgery acquired through IntraLase.

Product overview

Abbott Medical Optics offers the Verisyse Lens, a phakic intraocular lens product for vision correction. Based on market data, Abbott Medical leads the Verisyse Lens market with approximately 56% global market share. The company operates in the ophthalmic medical devices sector, competing with other major players including Ophtec BV (44% market share) and others in the broader refractive error correction market.

Differentiator

Problem solved

Functional benefit

Brands

• Verisyse Lens: Phakic intraocular lens for vision correction procedures

Products and services

• Verisyse Lens The Verisyse Lens is a phakic intraocular lens (IOL) used in minimally invasive vision correction procedures to treat refractive errors (myopia, hyperopia, astigmatism) in patients who prefer a lens-based alternative to laser-based LASIK surgery. It is sold to hospitals, ambulatory surgery centers, and ophthalmologists worldwide.

Quantifiable outcome

• 56% market share in global Verisyse Lens Market

Segments1 record

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Scale indicators3 records

Recent moves3 records

Expansion highlights3 records

Broad incumbents

• Carl Zeiss Meditec: Provides refractive surgery lasers, surgical microscopes, and IOLs; overlaps with AMO through refractive surgery systems and ophthalmic surgical workflows.
• Alcon: Broad incumbent in ophthalmic surgery and vision care; competes across cataract IOLs, refractive surgery equipment, and contact lens solutions, providing overlapping capabilities to AMO's portfolio.
• Johnson & Johnson Vision: Large incumbent covering cataract IOLs, refractive surgery (LASIK), and contact lenses; competes in adjacent ophthalmic device categories that surround AMO's phakic IOL business.
• HOYA Corporation: Manufactures intraocular lenses and ophthalmic surgical products through its eye care division, providing direct overlap in the IOL category that frames phakic IOL demand.
• Bausch + Lomb: Major ophthalmic player with surgical IOL, contact lens, and dry eye offerings, overlapping with AMO's historical and current portfolio areas.

Regional players

• CooperVision: Major contact lens manufacturer relevant to AMO's contact lens and dry eye product areas referenced in the firm's short description, though its core is refractive contact lenses rather than surgical IOLs.

Direct peers

• STAAR Surgical: Specialist in phakic intraocular lenses (notably the EVO ICL family) targeting the same refractive surgery patient population as Verisyse, with overlapping surgeon call points and product positioning.
• Ophtec BV: Direct competitor in the Verisyse-style phakic IOL segment, holding the remaining ~44% of the global Verisyse Lens market and competing head-to-head on surgical implant technology for refractive correction.

Emerging players

• Nidek: Japanese ophthalmic device manufacturer of refractive surgery lasers and diagnostic equipment, serving the same refractive surgery clinics and competing for surgical capex budgets.
• Rayner Intraocular Lenses: Specialist IOL manufacturer offering cataract and supplementary IOLs; competes for the same ophthalmic surgical channel and surgeon relationships as AMO's Verisyse business.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/AbbottNews
• Facebookfacebook.com/AbbottCareers
• LinkedInlinkedin.com/company/abbott

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Abbott Medical Optics